Trends in Stomach Cancer Burden in China: A Joinpoint and APC Analysis Based on GBD 2021
In the next decade, China's ASIR and ASMR for stomach cancer will continue to decline. However, despite the decrease in incidence, the overall burden of stomach cancer in China will remain significantly higher than the global average. The burden of stomach cancer in China will be a major public health challenge, given the country's large population base and aging population.
Authors
- Qian Zhou (ORCID: https://orcid.org/0000-0002-2249-0739)
- Ying Su (ORCID: https://orcid.org/0000-0001-8322-0655)
- Wei Wang (ORCID: https://orcid.org/0000-0001-7838-2430)
- Lili Zhang (ORCID: https://orcid.org/0000-0002-9341-5832)
- Juan Su (ORCID: https://orcid.org/0000-0001-7035-2560)
- Huiling Wei
- Xiangying Xie (ORCID: https://orcid.org/0009-0002-1845-8530)
Institutions
- Wuhan University (CN)
- Renmin Hospital of Wuhan University (CN)
Publication Details
- Journal
- Journal of Gastroenterology and Hepatology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1111/jgh.16956
- Citations
- 5
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 7.59